- Home
- GRI vs ZAPP Comparison
GRI vs ZAPP Comparison
Compare GRI & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- ZAPP
- Stock Information
- Founded
- GRI 2018
- ZAPP 2017
- Country
- GRI United States
- ZAPP Thailand
- Employees
- GRI N/A
- ZAPP N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- ZAPP Motor Vehicles
- Sector
- GRI Health Care
- ZAPP Consumer Discretionary
- Exchange
- GRI Nasdaq
- ZAPP Nasdaq
- Market Cap
- GRI 6.1M
- ZAPP 5.1M
- IPO Year
- GRI N/A
- ZAPP N/A
- Fundamental
- Price
- GRI $0.72
- ZAPP $1.12
- Analyst Decision
- GRI Strong Buy
- ZAPP
- Analyst Count
- GRI 2
- ZAPP 0
- Target Price
- GRI $11.50
- ZAPP N/A
- AVG Volume (30 Days)
- GRI 182.9K
- ZAPP 208.3K
- Earning Date
- GRI 11-14-2024
- ZAPP 01-28-2025
- Dividend Yield
- GRI N/A
- ZAPP N/A
- EPS Growth
- GRI N/A
- ZAPP N/A
- EPS
- GRI N/A
- ZAPP N/A
- Revenue
- GRI N/A
- ZAPP N/A
- Revenue This Year
- GRI N/A
- ZAPP N/A
- Revenue Next Year
- GRI N/A
- ZAPP $53,347.33
- P/E Ratio
- GRI N/A
- ZAPP N/A
- Revenue Growth
- GRI N/A
- ZAPP N/A
- 52 Week Low
- GRI $0.30
- ZAPP $0.70
- 52 Week High
- GRI $65.00
- ZAPP $19.10
- Technical
- Relative Strength Index (RSI)
- GRI 44.58
- ZAPP 33.87
- Support Level
- GRI $0.68
- ZAPP $1.20
- Resistance Level
- GRI $0.77
- ZAPP $1.47
- Average True Range (ATR)
- GRI 0.07
- ZAPP 0.11
- MACD
- GRI -0.01
- ZAPP 0.00
- Stochastic Oscillator
- GRI 16.44
- ZAPP 14.63
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.